MBRX — Moleculin Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Moleculin Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	C2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	70.9	43.1	23.6	4.28	8.88
Net Total Receivables	0.496	1.05	1.52	0.011	0.011
Prepaid Expenses
Total Other Current Assets
Total Current Assets	72.5	45.6	26.3	5.19	9.69
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.445	0.678	0.796	0.583	0.392
Net Intangible Assets
Other Long Term Assets
Total Assets	84.1	57.4	38.2	16.9	22.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.62	4.82	6.82	5.36	6.85
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.1	5.23	12.1	5.72	7.12
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	79	52.2	26.1	11.2	15
Total Liabilities & Shareholders' Equity	84.1	57.4	38.2	16.9	22.1
Total Common Shares Outstanding